Cargando…

Do the frail experience more adverse events from intensive blood pressure control? A 2-year prospective study in the Irish Longitudinal Study on Ageing (TILDA)

BACKGROUND: The 2018 European Society of Cardiology/European Society of Hypertension (ESC/ESH) guidelines for management of hypertension in adults aged ≥65 years recommend a blood pressure (BP) treatment target of 130–139/70–79 mmHg if tolerated. Randomised controlled trials have advocated for lower...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Donoghue, Patrick, O'Halloran, Aisling M., Kenny, Rose Anne, Romero-Ortuno, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860911/
https://www.ncbi.nlm.nih.gov/pubmed/35243271
http://dx.doi.org/10.1016/j.eclinm.2022.101304
_version_ 1784654768501686272
author O'Donoghue, Patrick
O'Halloran, Aisling M.
Kenny, Rose Anne
Romero-Ortuno, Roman
author_facet O'Donoghue, Patrick
O'Halloran, Aisling M.
Kenny, Rose Anne
Romero-Ortuno, Roman
author_sort O'Donoghue, Patrick
collection PubMed
description BACKGROUND: The 2018 European Society of Cardiology/European Society of Hypertension (ESC/ESH) guidelines for management of hypertension in adults aged ≥65 years recommend a blood pressure (BP) treatment target of 130–139/70–79 mmHg if tolerated. Randomised controlled trials have advocated for lower BP, but this may have adverse outcomes in the frail. Yet, definitions of frailty vary. METHODS: Using a prospective, observational study design, we compared two frailty classifications in their ability to predict short-term adverse outcomes associated with intensive BP control (<130/70 mmHg) in The Irish Longitudinal Study on Ageing (TILDA). Data from participants aged ≥65 treated for hypertension in Wave 1 (W1) between October 2009 and June 2011 were analysed. Frailty was identified by Frailty Phenotype (FP) and the Clinical Frailty Scale (CFS). We formulated 8 participant groups based on frailty-BP combinations. Outcomes at wave 2 (W2) in 2012–2013 were analysed with adjusted binary logistic regression models. FINDINGS: Of 1920 W1 participants aged ≥65 and treated for hypertension, 1229 had full BP/FP and 1282 BP/CFS data. While the FP only identified risk of hospitalisation associated with intensive BP treatment, intensively treated frail-by-CFS participants had no increased or decreased risk of adverse outcomes, but those treated above the target had a higher risk of falls/fractures. In the non-frail by FP, intensive blood pressure treatment was associated with reduced risk of falls/fractures. INTERPRETATION: Different frailty classifications may have different prognostic implications for the purpose of the application of hypertension management guidelines. Our study had limited power due to low frailty prevalences, so further research is needed. Guidelines should specify the recommended frailty identification method/s. In the frail, therapy personalisation is needed.
format Online
Article
Text
id pubmed-8860911
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88609112022-03-02 Do the frail experience more adverse events from intensive blood pressure control? A 2-year prospective study in the Irish Longitudinal Study on Ageing (TILDA) O'Donoghue, Patrick O'Halloran, Aisling M. Kenny, Rose Anne Romero-Ortuno, Roman EClinicalMedicine Articles BACKGROUND: The 2018 European Society of Cardiology/European Society of Hypertension (ESC/ESH) guidelines for management of hypertension in adults aged ≥65 years recommend a blood pressure (BP) treatment target of 130–139/70–79 mmHg if tolerated. Randomised controlled trials have advocated for lower BP, but this may have adverse outcomes in the frail. Yet, definitions of frailty vary. METHODS: Using a prospective, observational study design, we compared two frailty classifications in their ability to predict short-term adverse outcomes associated with intensive BP control (<130/70 mmHg) in The Irish Longitudinal Study on Ageing (TILDA). Data from participants aged ≥65 treated for hypertension in Wave 1 (W1) between October 2009 and June 2011 were analysed. Frailty was identified by Frailty Phenotype (FP) and the Clinical Frailty Scale (CFS). We formulated 8 participant groups based on frailty-BP combinations. Outcomes at wave 2 (W2) in 2012–2013 were analysed with adjusted binary logistic regression models. FINDINGS: Of 1920 W1 participants aged ≥65 and treated for hypertension, 1229 had full BP/FP and 1282 BP/CFS data. While the FP only identified risk of hospitalisation associated with intensive BP treatment, intensively treated frail-by-CFS participants had no increased or decreased risk of adverse outcomes, but those treated above the target had a higher risk of falls/fractures. In the non-frail by FP, intensive blood pressure treatment was associated with reduced risk of falls/fractures. INTERPRETATION: Different frailty classifications may have different prognostic implications for the purpose of the application of hypertension management guidelines. Our study had limited power due to low frailty prevalences, so further research is needed. Guidelines should specify the recommended frailty identification method/s. In the frail, therapy personalisation is needed. Elsevier 2022-02-19 /pmc/articles/PMC8860911/ /pubmed/35243271 http://dx.doi.org/10.1016/j.eclinm.2022.101304 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Articles
O'Donoghue, Patrick
O'Halloran, Aisling M.
Kenny, Rose Anne
Romero-Ortuno, Roman
Do the frail experience more adverse events from intensive blood pressure control? A 2-year prospective study in the Irish Longitudinal Study on Ageing (TILDA)
title Do the frail experience more adverse events from intensive blood pressure control? A 2-year prospective study in the Irish Longitudinal Study on Ageing (TILDA)
title_full Do the frail experience more adverse events from intensive blood pressure control? A 2-year prospective study in the Irish Longitudinal Study on Ageing (TILDA)
title_fullStr Do the frail experience more adverse events from intensive blood pressure control? A 2-year prospective study in the Irish Longitudinal Study on Ageing (TILDA)
title_full_unstemmed Do the frail experience more adverse events from intensive blood pressure control? A 2-year prospective study in the Irish Longitudinal Study on Ageing (TILDA)
title_short Do the frail experience more adverse events from intensive blood pressure control? A 2-year prospective study in the Irish Longitudinal Study on Ageing (TILDA)
title_sort do the frail experience more adverse events from intensive blood pressure control? a 2-year prospective study in the irish longitudinal study on ageing (tilda)
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860911/
https://www.ncbi.nlm.nih.gov/pubmed/35243271
http://dx.doi.org/10.1016/j.eclinm.2022.101304
work_keys_str_mv AT odonoghuepatrick dothefrailexperiencemoreadverseeventsfromintensivebloodpressurecontrola2yearprospectivestudyintheirishlongitudinalstudyonageingtilda
AT ohalloranaislingm dothefrailexperiencemoreadverseeventsfromintensivebloodpressurecontrola2yearprospectivestudyintheirishlongitudinalstudyonageingtilda
AT kennyroseanne dothefrailexperiencemoreadverseeventsfromintensivebloodpressurecontrola2yearprospectivestudyintheirishlongitudinalstudyonageingtilda
AT romeroortunoroman dothefrailexperiencemoreadverseeventsfromintensivebloodpressurecontrola2yearprospectivestudyintheirishlongitudinalstudyonageingtilda